The List Gets Cut Before You Know There Was a List
When two health systems merge, two vendor lists become one. The rationalization process does not ask which product is better. It asks which supplier the combined system cannot afford to lose.
The Signal
In April 2026, Sutter Health and Allina Health signed a letter of intent to merge.
Thirty-nine hospitals. More than four hundred care sites. A combined system valued at $26 billion, targeting close by the end of the year.
When that close happens, two item masters become one. Two GPO contracts get reconciled against each other. Two approved vendor lists, built independently, in different markets, over years, get consolidated into one. The process is called vendor rationalization. It is not a review of product quality. It is a rank-ordering of which suppliers the combined system cannot afford to lose, based on utilization volume, outcomes evidence, pricing leverage, and account relationship depth on both sides of the merger before anyone publishes a list.
The Sutter rep in California is being benchmarked against contracts the Allina supply chain team negotiated in Minnesota. They have never seen those contracts. They do not know the utilization volumes on the other side. They do not know whether they are priced above or below the Allina equivalent. They are finding out when the approved vendor list comes out, which is the wrong moment to find out.
Sutter-Allina is not unique. Hospital M&A cleared $41 billion in transaction value in Q1 2026 alone. Every merger contains a rationalization process. Most commercial organizations find out about it at the same stage: after the list is drafted.
The information that governs the outcome was public before the letter of intent was signed.
The Mechanic
Vendor rationalization in a merged system is not a buying decision. It is a scoring process, and it runs on three inputs that are almost entirely in writing before the commercial team shows up.
The first input is utilization data. The combined system will pull volumes from both predecessor institutions and compare them against contract terms. The supplier with higher utilization relative to contract commitment survives consolidation. The supplier whose volume is concentrated in one legacy institution and absent in the other is exposed. This data is not secret. It exists in the GPO member portals and in the health system's own supply chain analytics. The rep who has asked about utilization benchmarks relative to contract commitment has a number to defend. The rep who has not is invisible to the scoring model.
The second input is enterprise-level value documentation. Rationalization committees do not read clinical sell sheets. They read outcomes summaries tied to the system's stated strategic priorities. If the combined system has published integration priorities, and most do, in press releases, board communications, and investor-facing materials, those stated priorities are the evaluation framework. A supplier who has documented their value in the language of the system's own published goals clears the model. A supplier whose only documentation is a clinical case built for a single site does not.
The third input is relationship depth on both sides. The question the rationalization committee is asking is: which supplier can serve this enterprise, not just the accounts they already own? A rep with deep relationships in Sutter who has never touched Allina represents a geographic concentration risk. The commercial organization that identified the merger in April and initiated a relationship-mapping conversation before the close date is starting from a different position.
This is what reading the room means in an M&A environment. Not discovery questions. Not VOC surveys. Reading what is already written, the LOI filings, the integration press releases, the GPO contract calendars, the health system's stated strategic direction, before the conversation happens. The commercial organization that reads the room before the merger closes is present at the rationalization conversation. The one that reads the vendor list after the fact is reading a decision that has already been made.
The fear in this room is irrelevance, being cut not because the product was wrong but because the account relationship was shallow on the wrong side of a merger nobody tracked. The fuel is that every relevant document was public. The LOI is in SEC filings and press coverage. The integration priorities are in health system communications. The GPO contract landscape is on Premier and Vizient member portals. None of it requires a special source. All of it was in the room.
The Move
This week, run one check on your most important health system account.
Start with a single search: the account name plus "merger," "acquisition," or "system integration." Check the last twelve months. If they are in a transaction, announced or recently closed, pull the integration press release. Find the stated priorities for the combined system. Those priorities are the evaluation framework the rationalization committee is already using.
If there is no merger activity, run the same check on their GPO affiliation. When is their Premier or Vizient contract window? That calendar is in writing. It is governing the shape of your next renewal conversation whether you know it or not.
One account. One search. Fifteen minutes. Different conversation.
Dr. Gunter Wessels is the founder of LiquidSMARTS℠, a commercial engineering firm for medical technology companies. LiquidSMARTS℠ guarantees 10% pipeline velocity improvement in 90 days.